showed that purified recombinant RP534 PLA possessed the predicted PLA 2 and lyso-3 PLA 2 activities based on what has been published for P. aeruginosa ExoU. RP534 also 4 displayed PLA 1 activity under the conditions tested whereas ExoU did not. In addition, 5 recombinant RP534 displayed a basal PLA activity that could hydrolyze 6 phosphatidylcholine in the absence of any eukaryotic cofactors. Interestingly, the addition 7 of bovine liver superoxide dismutase 1 (SOD1), a known activator of P. aeruginosa ExoU, 8 resulted in an increased rate of RP534-catalyzed phospholipid hydrolysis indicating that 9 mechanisms of activation of the ExoU family of PLAs may be evolutionarily conserved. 10
to whether SOD1 is the only P. aeruginosa ExoU activator. Based on homology to P. 1 aeruginosa ExoU, the goal of the present study was to characterize the R. prowazekii RP534 2 protein to determine if it is a bona fide PLA and whether it shares the SOD1-dependent 3 activation properties of ExoU. 4
MATERIALS AND METHODS 5
Cell growth and chemicals. Escherichia coli was routinely grown in Luria Bertani (LB 6 Lennox) broth (Difco) supplemented with 100 µg/ml of ampicillin for plasmid maintenance 7 µCi µL -1 ) was from GE Healthcare. All other phospholipids were purchased from Avanti Polar 15
Lipids. 16
Expression plasmid construction and mutagenesis. Molecular cloning techniques were 17 previously described (18) . The R. prowazekii RP534 gene was cloned into the pET16b 18 expression vector (Novagen) to incorporate an amino-terminal decahistidine tag (plasmid 19 designated as pET16b-N-His 10 -RP534). Site-directed mutagenesis was performed on pET16b-20 N-His 10 -RP534 using Stratagene's QuikChange system to change a serine residue at position 100 21
to an alanine (S100A). A second, separate mutant was constructed by changing aspartic acid 22 on November 13, 2017 by guest http://jb.asm.org/ Downloaded from indacene-3-pentanoyl)-2-hexyl-sn-glycero-3-phosphoethanolamine)] substrate differs in that the 1 fluorescent moiety is conjugated at the sn-1 position and the sn-2 fatty acyl group is non-2 hydrolysable, and is used to measure the activity of PLA 1 enzymes. Substrates were dissolved 3 into 50 mM MOPS, 50 mM NaCl, pH 7.4 and assay conditions are described in the legends to 4
Figures 3, 4, and 5. Samples were removed from reactions with time and assayed for 5 fluorescence on a NanoDrop 3300 Micro-Volume Fluorospectrometer (Thermo Scientific) using 6 470 nm excitation/511 emission. The activity of purified N-His 10 -RP534 protein was also tested 7 in the presence of the PLA inhibitors methyl arachidonyl fluorophosphonate (MAFP, 8 concentrations given in Fig. 3C ) or arachidonyl trifluoromethyl ketone (AACOCF 3 ) at 10 µM. 9
The MAFP was purchased as a methylacetate solution that was evaporated prior to dissolution of 10 the MAFP directly into assay buffer. The AACOCF 3 was dissolved in ethanol and added 11 directly to the PLA assays. Ethanol alone was included as a vehicle control. 12
Immunoprecipitation of active RP534 from lysed cell extracts of purified R. prowazekii. All 13 experiments described in this study were performed using the Madrid E strain of R. prowazekii 14 (hen egg yolk sac passage # 282) purified as previously described (18) . For immunoprecipitation 15 of RP534 protein from R. prowazekii, purified rickettsiae were washed and suspended in 4 mL of 16 buffer A [135 mM NaCl, 2.7 mM KCl, 5.4 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 , 5 mM βME, and 17
Roche's EDTA-free complete protease inhibitor cocktail (PIC, at manufacturer's suggested 18 concentration), pH 7.4]; lysed by ballistic shearing and cleared of debris (18) . R. prowazekii 19 lysed cell extracts (~5 mg total protein, measured using the BioRad DC protein assay) were 20 incubated with 10 µL Protein A Sepharose beads (Pierce) for 10 min at 4 o C with agitation 21 followed by incubation with 24 µg of affinity-purified anti-RP534 antibody and 10 µL by SDS-PAGE (10% Tris-glycine). Gels were stained with BioRad Biosafe Coomassie, proteins 3 were excised, and analyzed by tandem mass spectrometry. Analysis of RP534 protein by 4 immunoblotting was performed using the protocol described in (8) . Anti-RP534 rabbit 5
antiserum was used at a 1:500 dilution, peroxidase-conjugated anti-rabbit secondary antibody 6 (Sigma) was used at 1:2000 dilution, blots were developed using enhanced chemiluminescence 7 (HRP ECL from GE Healthcare), and visualized using a BioRad ChemiDoc XRS gel 8 documentation system. 9
For isolation and assay of RP534 PLA activity from purified R. prowazekii lysed cell 10 extracts (~2 mg total protein), the IP protocol described above was modified as follows. The 11
Protein A pre-clearing step was performed for 45 min, the affinity-purified anti-RP534 antibody 12 and 10 µL Protein A step was performed for 2 h, beads were washed in 0.2 mL of buffer A (no 13 PIC), and protein was eluted in a final volume of 0.25 mL with elution buffer containing 5mM 14 βME. The IP flow-through, washes, and eluate were tested for PLA activity using fluorogenic 15 substrates as described above and in the legend to Figure 5 . 16
RESULTS

17
In vitro PLA 2 activity of purified recombinant RP534 protein. Considering that the R. 18 prowazekii RP534 open reading frame is a homologue of the P. aeruginosa ExoU PLA 2 19 cytotoxin we predicted that RP534 would also require the addition of eukaryotic cofactor(s) to 20 observe PLA activity. Thus, the known activator of P. aeruginosa ExoU, bovine liver SOD1 21 (35) OA as substrate (Fig. 1C, open squares) and ~35% of the total when PC-AA was the substrate 11 ( Fig. 1C, open triangles) . We observed a dramatic increase in the reaction rate with both the PC-12 OA-and PC-AA-containing LUV substrates when RP534 PLA 2 activity was assayed in the 13 presence of bovine liver SOD1 (Fig. 1C , compare closed diamonds and circles to open squares 14 and triangles, respectively). Control reactions where the LUV substrates were incubated with 15 SOD1 alone produced negligible amounts of free fatty acid (Fig. 1B, lane 1) . Figure 1D shows 16 that SOD1-mediated activation of RP534 PLA 2 activity was saturated at an ~5:1 molar ratio 17 (SOD1:RP534). Intriguingly, we tested SOD1 from other sources including bacteria, human 18 erythrocyte, and bovine erythrocyte but none were able stimulate RP534 activity (data not 19 shown). Our data along with previous results for P. aeruginosa ExoU (35) suggest that it is not 20 the dismutase enzymatic activity of SOD1 that is affecting RP534 activity in vitro. 21 We also purified and assayed two other recombinant N-His 10 -RP534 proteins, each 22 harboring a single alanine substitution at putative active site residue S100 or D264 (Fig. 1A,  23 lanes 2 & 3). These sites were selected based on alignment with P. aeruginosa ExoU and other 24 patatin homologues (36) . Figure 1B shows substrates are labeled in the sn-2 position and thus, the activity of a PLA 1 will produce [ hydrolysis in the presence of SOD1 after 25 minutes of incubation but this observation was not 10 pursued further. As a control we verified that incubation of either substrate with SOD1 alone 11
showed no PLA activity (data not shown). 12 As further evidence that RP534 is a bona fide PLA enzyme, we tested its ability to 13 hydrolyze the PED6 substrate in the presence of two known inhibitors of PLA 2 activity. Figure  14 3C shows inhibition of RP534 PLA 2 activity by nanomolar amounts of the potent, irreversible 15 inhibitor MAFP (Fig. 3C) . The reversible inhibitor AACOCF 3 inhibited recombinant RP534 16 activity at 10 µM (data not shown). 17
Mechanism of SOD1-stimulated RP534 PLA activity. The fact that RP534-mediated 18 hydrolysis of the fluorogenic phospholipid substrates was entirely SOD1-dependent over a short 19 time course furnished us with a sensitive assay to examine the mechanism of SOD1-mediated 20 activation. The RP534 interaction with the PED6 substrate was tested using the RP534(D264A) 21 mutant as a potential inhibitor of wild type RP534 PLA 2 activity. We first verified that the 22 RP534(S100A) and RP534(D264A) mutants were unable to hydrolyze the PED6 substrate in the 23 presence or absence of SOD1 (data not shown). For the inhibition experiments, the PED6 24 substrate was pre-incubated with increasing amounts of the RP534(D264A) mutant protein for 1 twenty minutes followed by the addition of wild type RP534 and SOD1 to the reaction. Figure  2 4A shows that the addition of increasing amounts of RP534(D264A) protein to the reaction 3 resulted in a concomitant reduction in the rate of SOD1-dependent PED6 hydrolysis by wild type 4 RP534. These data raised the interesting question of whether the RP534(D264A) mutant was 5 sequestering the substrate or specifically forming an inactive complex with the wild type RP534 6 protein. Figure 4B shows that pre-incubation of the PED6 substrate with the RP534(D264A) 7 mutant protein also inhibited the activity of snake venom PLA 2 protein indicating that the 8 RP534(D264A) mutant protein may be sequestering the PED6 substrate. As a control, we tested 9 a non-PLA rickettsial protein previously characterized by our laboratory (18) to show that the 10 observed RP534(D264A)-mediated inhibition of RP534 PLA 2 activity was specific (Fig. 4C) . 11
Together these data suggest a mechanism in which RP534 binds to its substrate and the rate of 12 hydrolysis is stimulated upon the addition of SOD1. 13
The RP534 PLA is assayable in lysed cell extracts of R. prowazekii. Recombinant N-His 10 -14 RP534 protein was used to prepare rabbit polyclonal antiserum to probe whether RP534 is 15 expressed and active in purified R. prowazekii. Figure 5A shows that RP534 protein was 16 isolated from rickettsial lysed cell extracts by immunoprecipitation and the identity of the protein 17 was verified by mass spectrometry. These data confirm two previous MS-based proteomic 18 studies that detected RP534 in purified R. prowazekii (12, 43) . The crude R. prowazekii lysed 19 cell extracts displayed both SOD1-dependent (Fig. 5B, squares) and SOD1-independent (Fig.  20 5B, diamonds) PLA 2 activities using the PED6 substrate. The observation of SOD1-independent 21 PLA 2 activity in R. prowazekii extracts using a fluorescent-based assay was not unexpected in 22 light of a previous report (26) . The SOD1-dependent increase in PLA 2 activity in the crude 23 extracts (Fig. 5B) was statistically significant compared to the unstimulated samples, thus 24
suggesting that the observed increase is due to activation of RP534. The large experimental errorobserved was likely due to the unavoidable variability inherent to preparations of R. prowazekii 1 isolated from embryonated hen egg yolk sacs. 2
The RP534 protein was immuno-affinity purified from the R. prowazekii extracts using 3 the anti-RP534 antibody and displayed the expected SOD1-dependent PLA 2 activity when 4 assayed using the PED6 substrate (Fig. 5C) . Interestingly, shorter incubation times between the 5 anti-RP534 antibody and the R. prowazekii lysed cell extracts yielded protein with higher 6 specific PLA 2 activity whereas overnight incubations resulted in total inactivation of SOD1-7 stimulated PLA 2 activity (data not shown). Together, these data suggest that R. prowazekii 8 synthesizes RP534 protein and that in lysed cell extracts the protein becomes inactive with time. 9
This observation is extremely interesting considering that purified recombinant N-His 10 -RP534 10 purified from E. coli does not lose activity over weeks of storage at 4 o C. We are further 11 studying this phenomenon. 12
DISCUSSION 13
The present study has shown that purified, recombinant RP534 possesses PLA 1 , PLA 2 14 and lyso-PLA 2 activities and that bovine liver SOD1 can stimulate RP534 activity in vitro. The 15 evidence demonstrating that RP534 is a bona fide PLA protein include: (i) the observation that 16 the recombinant RP534 PLA activities were measurable in the absence of any eukaryotic co-17 factors (Fig. 1B & C) ; (ii) the deleterious effect of mutating putative active site residues S100 18 and D264 on RP534 PLA activity (Fig. 1B) ; and (iii) the inhibition of RP534 activity by known 19 the PLA 2 inhibitors MAFP and AACOCF 3 ( Fig. 3C and data not shown) . The R. prowazekii 20
ExoU homologue also displayed some distinguishing characteristics compared to what has been 21 published for P. aeruginosa ExoU by several independent groups (14, 27, 28, 36, 37, 42, 44) . conserved. In addition, the RP534 protein was shown to be expressed in R. prowazekii purified 11 from embryonated hen egg yolk sacs and when purified by immunoprecipitation displayed the 12 expected SOD1-stimulated PLA 2 activity when assayed with the sensitive PED6 fluorogenic 13 substrate (Fig. 5) . The fact that the RP534 PLA reaction rates were slow compared to the snake 14 venom PLA 2 controls seems to fit with the obligate intracytoplasmic lifestyle of R. prowazekii 15 which is typified by slow growth and filling of the host cell cytosol with pathogen prior to lysis 16 and release. 17
The RP534 PLA demonstrated notable differences in activity depending upon the 18 substrate used in the assay. In the absence of SOD1, the RP534 PLA showed a higher rate of 19 [ 14 C]PC-OA hydrolysis compared to [ 14 C]PC-AA when these substrates were presented as 20 PC/PS-mixed LUVs (Fig. 1C) . Although the addition of SOD1 to the reaction resulted in similar 21 rates of [ (Fig. 1C) . Furthermore, the PED6 substrate, which is composed of a 23 modified ethanolamine head group and a fluorophore in the sn-2 position, was only hydrolyzed 24 by RP534 in the presence of SOD1 over a short time course (Fig. 3A) . Together these data 25 on November 13, 2017 by guest http://jb.asm.org/ Downloaded from suggest that the fatty acyl group in the sn-2 position and the nature of the polar head group may 1 influence RP534 substrate recognition prior to its activation by SOD1 or any other unknown 2 eukaryotic co-factor(s). 3
The identification of ExoU homologues in the obligate intracellular pathogenic rickettsiae 4 and the free-living, opportunistic pseudomonad raises interesting questions regarding the 5 ancestral acquisition and evolution of ExoU function in these phylogenetically unrelated 6 organisms. It is postulated that the P. aeruginosa exoU gene was acquired via horizontal transfer 7 as indicated by its location in the genome and different G/C content compared to the core 8 genome (23). Conversely, the R. prowazekii RP534 gene displays a high A/T content that is a 9 hallmark of the R. prowazekii genome (6) indicating that it was likely acquired by an early 10 ancestor. The homology between the P. aeruginosa ExoU and R. prowazekii RP534 PLAs is 11 limited to the N-terminus which contains the putative PLA catalytic domains. Conversely, their 12 C-termini are large domains constituting half of the ~70 KDa protein sequence but share no 13 identifiable homology. Divergence of their C-terminal domains may have been influenced by 14 the different mechanisms by which these pathogens secrete the protein into the host cell milieu. 15
P. aeruginosa secretes ExoU via the type three secretion system which is not present in any 16
Rickettsia species genome sequenced to date. The RP534 homologue of R. typhi has been shown 17 to be released to the host cell cytosol (29) 
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While the pathogenic role of the R. prowazekii ExoU homologue remains unknown, the 1 ExoU homologue of R. typhi (RT0522) has been recently characterized and shown to be present 2 in the host cytosol during infection (29) . Similar to P. aeruginosa ExoU, secretion of the 3 rickettsial ExoU PLA homologues would facilitate a perhaps necessary encounter with a 4 eukaryotic activator, such as SOD1, to mediate the desired effects on the host cell. Interestingly, 5 purified recombinant R. typhi RT0522 PLA activity was reported to be dependent upon the 6 presence of eukaryotic cell extracts to stimulate activity in vitro and displayed weaker activity 7 compared to purified P. aeruginosa ExoU when activity was assayed using a fluorogenic 8 phospholipid substrate (29) . In our assay system using fluorogenic substrates, the purified R. 9 prowazekii RP534 PLA had considerably greater PLA activity compared to purified recombinant 10 P. aeruginosa ExoU (Figs. 3A and B) and to that reported for R. typhi RT0522 (29) . 11
Considering that the R. prowazekii and R. typhi ExoU homolgues share >90% identity it will be 12 important to resolve these apparent discrepancies by assaying R. typhi ExoU activity using the 13 radio-labeled PC substrates employed in our study. Any similarities and/or differences might 14 reflect differences in the virulence of these two rickettsial pathogens. 15
Analyses of all sequenced rickettsial genomes reveal an intriguing difference with respect 16 to the status of ExoU homologues. Functional ExoU homologues are present in the typhus group 17 rickettsiae, R. prowazekii (RP534 from this study) and R. typhi (RT0522 from (29)), and 18 rickettsial ExoU homologues also appear to be intact in the distant relatives R. massiliae and R. 19 bellii (84% and 69% identity, respectively, with perfect conservation of putative active site 20 residues but their biochemical properties are unknown). Intriguingly, rickettsial ExoU 21 homologues in all other sequenced rickettsial genomes, including the spotted fever group (e.g., 22
R. rickettsii and R. conorii), are markedly degenerated/fragmented and may no longer be 23 functional. These genomic analyses may shed light on previous studies implicating PLA 2 as 24 critical to the interaction of both typhus group and spotted fever group rickettsiae with eukaryotichost cells (39, 46, 51, 54, 56) . Homologues of RP602, the other rickettsial patatin-like PLA, 1 have been identified in all sequenced rickettsial genomes to date. Interestingly, R. felis possesses 2 two additional plasmid-borne gene copies (10) . Thus, it is tempting to speculate that RP602 is a 3 major player in rickettsia-host interactions and that the ExoU homologues have been maintained 4 to play either a redundant or an evolved specialized role in the typhus group rickettsiae and 5 possibly in R. massiliae and R. bellii. Alternatively, rickettsial ExoU homologues may be 6 entirely dispensable and will eventually be lost from the core genome. In either case, one must 7 be cautious in making such assertions until the biological role of RP602 homologues is fully 8 established and the existing ExoU gene fragments from the spotted fever group rickettsiae are 9 examined for any remaining activity or function. Our current focus is on investigating the role of 10 RP534 PLA activity in R. prowazekii growth and pathogenesis. as a potential inhibitor of 0.07 mU µL -1 purified snake venom (Naja mossambica mossambica) 20 PLA 2 activity was determined as described in (A) except that SOD1 was omitted from the assay. 21 The asterisk denotes that all samples showed statistically significant inhibition compared to the 22 uninhibited control by a one-tailed T-test (P < 0.05). (C) The effect of titrated amounts of the N-23 His 6 -GpsA rickettsial protein as a control for non-specific inhibition of wild type N-His 10 -RP534 24 PLA activity was determined using the PED6 substrate at a final concentration of 2.97 µM. 
